Insulet's book value per share for the quarter that ended in Dec. 2023 was $10.48.
During the past 12 months, Insulet's average Book Value Per Share Growth Rate was 52.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 34.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 25.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Insulet was 81.60% per year. The lowest was -51.10% per year. And the median was 10.30% per year.
Insulet's current price is $166.25. Its book value per share for the quarter that ended in Dec. 2023 was $10.48. Hence, today's PB Ratio of Insulet is 15.86.
During the past 13 years, the highest P/B Ratio of Insulet was 232.51. The lowest was 10.41. And the median was 31.33.
Good Sign:
Insulet Corp stock PB Ratio (=15.72) is close to 10-year low of 14.88
Insulet Book Value per Share Historical Data
The historical data trend for Insulet's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Insulet Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Book Value per Share
1.21
9.14
8.04
6.85
10.48
Insulet Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Book Value per Share
6.85
7.21
7.94
8.70
10.48
Competitive Comparison
For the Medical Devices subindustry, Insulet's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insulet PB Ratio Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Insulet's PB Ratio distribution charts can be found below:
* The bar in red indicates where Insulet's PB Ratio falls into.
Insulet Book Value per Share Calculation
Insulet's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Insulet (NAS:PODD) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Insulet Book Value per Share Related Terms
Thank you for viewing the detailed overview of Insulet's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PODD has been successfully added to your 